Nele Dewit

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration

M. Quaglia, Y. Pijnenburg, E. Vanmechelen, 2022, International journal of molecular sciences.

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease

P. Worley, D. Salmon, D. Galasko, 2019, Alzheimer's & dementia.

Plasma p‐tau181/Aβ1‐42 ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ1‐42 and future cognitive decline

C. Rowe, R. Martins, C. Masters, 2022, medRxiv.

Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

K. Blennow, E. Vanmechelen, H. Zetterberg, 2022, Alzheimer's research & therapy.

Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

Y. Pijnenburg, E. Vanmechelen, C. Teunissen, 2023, Alzheimer's Research & Therapy.

P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles

P. Scheltens, P. Visser, B. Tijms, 2022, Alzheimer's research & therapy.